about
The eye-voice lead during oral reading in developmental dyslexiaFailure to learn a new spatial format in children with developmental dyslexia.Developmental dyslexia in a regular orthography: can the reading profile be reduced to strategic control?Psychosocial interventions for very early and early-onset schizophrenia: a review of treatment efficacy.Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.Visual perception skills: a comparison between patients with Noonan syndrome and 22q11.2 deletion syndrome.Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention.Adolescence is the starting point of sex-dichotomous COMT genetic effects.An Overview of Recent Findings on Social Anxiety Disorder in Adolescents and Young Adults at Clinical High Risk for Psychosis.Bridging the gap between different measures of the reading speed deficit in developmental dyslexia.Multiple stimulus presentation yields larger deficits in children with developmental dyslexia: a study with reading and RAN-type tasks.Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.Use of Transcranial Direct Stimulation in the Treatment of Negative Symptoms of Schizophrenia.Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect?All that glitters is not gold: prevalence and relevance of psychotic-like experiences in clinical sample of children and adolescents aged 8-17 years old.Is it still correct to differentiate between early and very early onset psychosis?Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.Dopamine dysfunction in 22q11 deletion syndrome: possible cause of motor symptoms.Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjectsPrevalence and Clinical Significance of Symptoms at Ultra High Risk for Psychosis in Children and Adolescents with Obsessive⁻Compulsive Disorder: Is There an Association with Global, Role, and Social Functioning?Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndromePrevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndromePublisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatmentNeurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal studyAntipsychotics Do Not Influence Neurological Soft Signs in Children and Adolescents at Ultra-High Risk for Psychosis: A Pilot StudyComorbid Personality Disorders in Individuals With an At-Risk Mental State for Psychosis: A Meta-Analytic ReviewComplete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart DefectsPeer Victimization and Onset of Social Anxiety Disorder in Children and Adolescents22q11 microdeletion syndrome and ultra-high risk for psychosis: The role of neurological soft signs as an independent marker of vulnerability for psychosis
P50
Q30447327-B7CD5D83-EAF0-4A86-93B5-B5862E500396Q30577407-C7D27B00-E13F-445C-88F2-E364F03FCA11Q38447387-FEB37571-A486-473B-B40B-5FB6077A6977Q38498552-27BFFD95-7676-4EBD-833F-791DBB1788ACQ38756852-99A35B27-9A83-4AC3-B83F-876E07C28649Q38853884-9256421A-5B45-4257-9399-3A93B379FAACQ39451594-B5E4BFF2-CE6B-4E1A-AAA4-364DA64B1D85Q41614666-26CDFC30-5E05-428A-A10A-4F60EE0BBBF6Q43073835-29FCA21B-B9B4-46E9-BED2-8CB661DBC134Q43796934-2ACDC5AE-F962-4FB7-AF72-BE3BB234F3F2Q45844169-163673DC-D8D0-4A5D-B79D-51D3F32DF935Q47730825-AAAF796B-C5F1-49C7-9F65-F806E434B279Q47914703-7B890528-A247-4E59-B3CD-871F5CBDB349Q47949210-6F228291-B031-40F8-BF79-D9FBC7B47BAAQ48043070-D714A503-3210-4497-AF57-7AA44BC935CEQ48069187-3BAAB600-3B0F-452B-A62A-ACF8E6E5735FQ48269581-91BBDF91-0888-4826-AA92-5E950558EDD9Q48558247-6DE567F5-DD46-4A5F-9B57-C8C9A2CE0795Q50551517-70B65642-C14C-42D3-9002-D93659D23BF9Q55216457-8F1E3A7B-8D0F-42BA-9A7D-EBF856EEC10BQ56977908-C107B365-B2D0-4365-A508-67711966D91EQ57063678-9CB4A901-B4DF-45FA-9CD1-5925DCC60764Q57170493-A30AD470-A280-4B0E-9BAF-D83B5A98E7BEQ58602435-39AE0CDF-9BCE-4B93-8C2B-3AECCCFEC933Q58695714-1CD17BE5-9568-4D29-9771-025031AE68E4Q91769102-6CCF7AC8-3810-479E-A7BA-119C23B13FA4Q91978857-1F67D0BC-EC56-4D46-88BC-EE59DA4068A4Q92105678-330E3156-1A6D-4BE7-8496-19AF0EB20E16Q92213737-7E32A705-05FC-44D8-B6A8-4EC911ED4DDBQ92589899-7CA1F367-CA26-4397-AAA2-CFA8F9E6C14CQ93384452-79A1D8E5-BBDE-47D0-B722-0BD9757643D9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria Pontillo
@en
Maria Pontillo
@nl
type
label
Maria Pontillo
@en
Maria Pontillo
@nl
prefLabel
Maria Pontillo
@en
Maria Pontillo
@nl
P31
P496
0000-0002-0083-0093